Related Experiment Video
Updated: Jul 19, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
Hyperhomocysteinemia and venous thromboembolism
1Hematology and Thrombosis Unit, Hospital San Paolo, University of Milan, Milan, Italy. marco.cattaneo@unimi.it
High homocysteine (Hcy) levels increase venous thromboembolism (VTE) risk. While vitamin treatment reduces VTE risk in severe cases, its benefit in mild/moderate hyperhomocysteinemia remains uncertain.
Area of Science:
- Biochemistry
- Genetics
- Cardiovascular Medicine
Background:
- Homocysteine (Hcy) is a key amino acid in methionine metabolism, influenced by B vitamins.
- Severe hyperhomocysteinemia (homocystinuria) due to genetic defects significantly elevates venous thromboembolism (VTE) risk.
- Vitamin therapy effectively reduces VTE risk in severe hyperhomocysteinemia.
Purpose of the Study:
- To investigate the association between mild/moderate hyperhomocysteinemia and VTE risk.
- To evaluate the potential benefit of vitamin treatment in reducing VTE risk in patients with mild/moderate hyperhomocysteinemia.
Main Methods:
- Review of case-control and prospective studies examining homocysteine levels and VTE.
- Analysis of the impact of vitamin supplementation on VTE risk in different hyperhomocysteinemia severity groups.
Main Results:
- Mild/moderate hyperhomocysteinemia, resulting from genetic and environmental interactions, is linked to increased VTE risk.
- The efficacy of vitamin treatment in mitigating VTE risk for mild/moderate hyperhomocysteinemia is not yet established.
Conclusions:
- Hyperhomocysteinemia, even in mild/moderate forms, represents a significant risk factor for VTE.
- Further research is needed to determine if vitamin supplementation can reduce VTE risk in individuals with mild/moderate hyperhomocysteinemia.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis IV: Nursing Management

